PMN
ProMIS Neurosciences

816
Loading...
Loading...
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7

Frequently Asked Questions

What is Market Cap of ProMIS Neurosciences Inc.?
What is the 52-week high for ProMIS Neurosciences Inc.?
What is the 52-week low for ProMIS Neurosciences Inc.?
What is ProMIS Neurosciences Inc. stock price today?
What was ProMIS Neurosciences Inc. stock price yesterday?
What is the PE ratio of ProMIS Neurosciences Inc.?
What is the Price-to-Book ratio of ProMIS Neurosciences Inc.?
What is the 50-day moving average of ProMIS Neurosciences Inc.?
How many employess does ProMIS Neurosciences Inc. has?

Latest PMN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.